Industry Veteran Hank Struik Appointed As LABSCO’s Chief Executive Officer
December 19, 2012
LABSCO, a leading distributor of innovative diagnostic technologies and laboratory products to hospitals, physician office laboratories and alternate healthcare settings, has appointed Hendrik “Hank” Struik as its new chief executive officer (CEO) to take the Company through its next growth phase. Struik will succeed Steve Nielsen, who will be transitioning from his role as chairman [...]
Whole Genome Maps to Aid in Outbreak Management and Surveillance of Food Borne Illnesses
December 19, 2012
Gaithersburg, Md.— OpGen, Inc. today announced the company has entered into a scientific and technical partnership with the University of California, Davis, (UC Davis) in cooperation with the FDA supported 100K Genome Project to create high resolution microbial genetic maps. The 100K Genome Project is a collaboration that was initiated by the U.S. Food and [...]
December 19, 2012
CARLSBAD, Calif., -- Life Technologies Corporation (NASDAQ: LIFE) announced today a new 400 base-pair sequencing kit for the Ion PGM™ Sequencer. The kit produces reads 60 percent longer than comparable high-throughput benchtop sequencers, generating more complete bacterial de novo assemblies with longer contiguous sequences. To see a video about the 400 bp kit and other [...]
Sartorius Stedim Biotech Expands Portfolio by Adding Cell Culture Media
December 19, 2012
Goettingen, – Sartorius Stedim Biotech (SSB), a leading international pharmaceutical and biotech supplier, today announced a substantial expansion of its product array in the cell culture range. The company signed a cooperation agreement with the Swissbased life science group Lonza on long-term, global collaboration in the field of cell culture media. Cell culture media are [...]
Fluidigm Introduces mRNA Sequencing Application for the C1™ Single-Cell Auto Prep System
December 19, 2012
SOUTH SAN FRANCISCO, Calif. –– Fluidigm Corporation (NASDAQ:FLDM) today introduced the mRNA sequencing application on its C1™ Single-Cell Auto Prep System. With this new C1 system application, researchers have an easy, end-to-end workflow for detailed transcriptome analysis of 96 single cells to rapidly study differential expression profiles of diverse cell populations. The C1 mRNA Seq [...]
Now Make Rapid Viscosity Measurements with Precise Temperature Control
December 19, 2012
Temperature dependence is one of the most important factors in determining viscosity so a minute variation can possibly lead to significantly erroneous results. With the advent of microVISC TC, microVISC is now capable of offering accurate viscosity measurement which would eliminate any uncertainty and allow users to adhere to the most stringent requirements. The Peltier-based [...]
December 18, 2012
Sartorius Stedim Biotech (SSB), a leading international pharmaceutical and biotech supplier, has entered into a global sales partnership with Umetrics AB, a Swedish software manufacturer. Umetrics is a highly specialized, leading provider of chemometrics software worldwide for modeling and optimizing biopharmaceutical development and manufacturing processes. The cooperation agreement provides that SSB will assume global marketing [...]
David A. Zapico Named Executive Vice President and Chief Operating Officer
December 18, 2012
BERWYN, Pa., -- AMETEK, Inc. (NYSE: AME) today announced the election of David A. Zapico as Executive Vice President and Chief Operating Officer, effective January 1, 2013. "I am very pleased to announce Dave Zapico's appointment to Executive Vice President and Chief Operating Officer. Dave has played an instrumental role in the success of AMETEK [...]
December 18, 2012
ALAMEDA, Calif. -- BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, and its subsidiaries OrthoCyte Corporation and LifeMap Sciences reported today a means of manufacturing seven distinct types of cartilage, bone, and tendon cells from human embryonic stem cells. The paper, scheduled to be [...]
Cellectis: an innovative anti-cancer approach
December 18, 2012
Paris, France, - Cellectis (Alternext: ALCLS), the genome engineering specialist, announces today the signing of a broad collaboration agreement with the University College of London (UCL) on the development of a therapy program to fight leukemia. This agreement builds on Cellectis’ therapeutic strategy to treat patients with B-cell leukemias. This therapy uses Cellectis’ proprietary genome [...]

